Values for preventing influenza-related morbidity and vaccine adverse events in children.

ABSTRACT:

Background

Influenza vaccination recently has been recommended for children 6-23 months old, but is not currently recommended for routine use in non-high-risk older children. Information on disease impact, costs, benefits, risks, and community preferences could help guide decisions about which age and risk groups should be vaccinated and strategies for improving coverage. The objective of this study was to measure preferences and willingness-to-pay for changes in health-related quality of life associated with uncomplicated influenza and two rarely-occurring vaccination-related adverse events (anaphylaxis and Guillain-Barré syndrome) in children.

Methods

We conducted telephone interviews with adult members selected at random from a large New England HMO (n = 112). Respondents

SUBMITTER: Prosser LA 

PROVIDER: S-EPMC1083419 | biostudies-literature | 2005 Mar

REPOSITORIES: biostudies-literature